Peter N. Monk Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB) University of Sheffield Biography Publications Institution JoVE Articles Peter N. Monk has not added a biography. If you are Peter N. Monk and would like to personalize this page please email our Author Liaison for assistance. Publications A Role for Tetraspanin Proteins in Regulating Fusion Induced by Burkholderia Thailandensis Medical Microbiology and Immunology. Apr, 2020 | Pubmed ID: 32253503 Characterization of Ocular Clinical Isolates of from Non-Contact Lens Related Keratitis Patients from South India Microorganisms. Feb, 2020 | Pubmed ID: 32075262 Hydrophobicity-Modulated Small Antibacterial Molecule Eradicates Biofilm with Potent Efficacy Against Skin Infections ACS Infectious Diseases. 04, 2020 | Pubmed ID: 32058691 Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections International Journal of Molecular Sciences. Oct, 2018 | Pubmed ID: 30279342 Monocyte Subsets Have Distinct Patterns of Tetraspanin Expression and Different Capacities to Form Multinucleate Giant Cells Frontiers in Immunology. 2018 | Pubmed ID: 29937768 A Role for the Tetraspanin Proteins in Salmonella Infection of Human Macrophages The Journal of Infection. 08, 2017 | Pubmed ID: 28602860 Tspan2: a Tetraspanin Protein Involved in Oligodendrogenesis and Cancer Metastasis Biochemical Society Transactions. 04, 2017 | Pubmed ID: 28408487 Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes PloS One. 2016 | Pubmed ID: 27467693 Distinct Regions of the Large Extracellular Domain of Tetraspanin CD9 Are Involved in the Control of Human Multinucleated Giant Cell Formation PloS One. 2014 | Pubmed ID: 25551757 C5a2 Can Modulate ERK1/2 Signaling in Macrophages Via Heteromer Formation with C5a1 and β-arrestin Recruitment Immunology and Cell Biology. Aug, 2014 | Pubmed ID: 24777312 Wild-type but Not Mutant SOD1 Transgenic Astrocytes Promote the Efficient Generation of Motor Neuron Progenitors from Mouse Embryonic Stem Cells BMC Neuroscience. Oct, 2013 | Pubmed ID: 24134124 C5a Receptor-dependent Cell Activation by Physiological Concentrations of Desarginated C5a: Insights from a Novel Label-free Cellular Assay Journal of Immunology (Baltimore, Md. : 1950). Nov, 2012 | Pubmed ID: 23041570 De Novo Peptide Design with C3a Receptor Agonist and Antagonist Activities: Theoretical Predictions and Experimental Validation Journal of Medicinal Chemistry. May, 2012 | Pubmed ID: 22500977 Tetraspanins: Gateways for Infection Infectious Disorders Drug Targets. Feb, 2012 | Pubmed ID: 22034932 A Comparison of in Vitro Properties of Resting SOD1 Transgenic Microglia Reveals Evidence of Reduced Neuroprotective Function BMC Neuroscience. Sep, 2011 | Pubmed ID: 21943126 Cooperative Role for Tetraspanins in Adhesin-mediated Attachment of Bacterial Species to Human Epithelial Cells Infection and Immunity. Jun, 2011 | Pubmed ID: 21464080 The Role of Tetraspanins in Fusion Biochemical Society Transactions. Apr, 2011 | Pubmed ID: 21428932 Contrasting Effects of Cerebrospinal Fluid from Motor Neuron Disease Patients on the Survival of Primary Motor Neurons Cultured with or Without Glia Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. Jul, 2011 | Pubmed ID: 21366496 Strategies for Targeting Tetraspanin Proteins: Potential Therapeutic Applications in Microbial Infections BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 2009 | Pubmed ID: 19894777 Mutant SOD1 G93A Microglia Have an Inflammatory Phenotype and Elevated Production of MCP-1 Neuroreport. Oct, 2009 | Pubmed ID: 19752764 Distinct Roles for Tetraspanins CD9, CD63 and CD81 in the Formation of Multinucleated Giant Cells Immunology. Jun, 2009 | Pubmed ID: 19489128 Astrocyte Function and Role in Motor Neuron Disease: a Future Therapeutic Target? Glia. Sep, 2009 | Pubmed ID: 19373940 The Human Complement Fragment Receptor, C5L2, is a Recycling Decoy Receptor Molecular Immunology. Mar, 2009 | Pubmed ID: 19100624 Endothelial Adhesion Receptors Are Recruited to Adherent Leukocytes by Inclusion in Preformed Tetraspanin Nanoplatforms The Journal of Cell Biology. Nov, 2008 | Pubmed ID: 18955551 Characterisation of Receptor Binding by the Chemotaxis Inhibitory Protein of Staphylococcus Aureus and the Effects of the Host Immune Response Molecular Immunology. Apr, 2007 | Pubmed ID: 17258808 The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding The Journal of Biological Chemistry. Feb, 2007 | Pubmed ID: 17158873 Recombinant Extracellular Domains of Tetraspanin Proteins Are Potent Inhibitors of the Infection of Macrophages by Human Immunodeficiency Virus Type 1 Journal of Virology. Jul, 2006 | Pubmed ID: 16775336 Microglia As Potential Contributors to Motor Neuron Injury in Amyotrophic Lateral Sclerosis Glia. Sep, 2005 | Pubmed ID: 15846792 Comparative Agonist/antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site The Journal of Biological Chemistry. May, 2005 | Pubmed ID: 15661745 Structural Requirements for the Inhibitory Action of the CD9 Large Extracellular Domain in Sperm/oocyte Binding and Fusion Biochemical and Biophysical Research Communications. Nov, 2003 | Pubmed ID: 14575715 Characterisation of C5a Receptor Agonists from Phage Display Libraries Biochemical Pharmacology. Nov, 2003 | Pubmed ID: 14563493 The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a Des-Arg(74) The Journal of Biological Chemistry. Mar, 2002 | Pubmed ID: 11773063 Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2 Journal of Virology. Apr, 2000 | Pubmed ID: 10729140 Pharmacological Characterization of Antagonists of the C5a Receptor British Journal of Pharmacology. Dec, 1999 | Pubmed ID: 10602324 Establecer un modelo de córnea ex vivo porcina para estudiar tratamientos farmacológicos contra la queratitis bacteriana Katarzyna Okurowska1,2, Sanhita Roy3, Praveen Thokala4, Lynda Partridge1,5, Prashant Garg3, Sheila MacNeil1,6, Peter N. Monk1,7, Esther Karunakaran1,2 1Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB), University of Sheffield, 2Department of Chemical and Biological Engineering, University of Sheffield, 3Hyderabad Eye Research Foundation, L V Prasad Eye Institute, 4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, 5Department of Molecular Biology and Biotechnology, University of Sheffield, 6Department of Materials Science and Engineering, University of Sheffield, 7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield JoVE 61156 Imunologia e Infecção
Establecer un modelo de córnea ex vivo porcina para estudiar tratamientos farmacológicos contra la queratitis bacteriana Katarzyna Okurowska1,2, Sanhita Roy3, Praveen Thokala4, Lynda Partridge1,5, Prashant Garg3, Sheila MacNeil1,6, Peter N. Monk1,7, Esther Karunakaran1,2 1Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB), University of Sheffield, 2Department of Chemical and Biological Engineering, University of Sheffield, 3Hyderabad Eye Research Foundation, L V Prasad Eye Institute, 4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, 5Department of Molecular Biology and Biotechnology, University of Sheffield, 6Department of Materials Science and Engineering, University of Sheffield, 7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield JoVE 61156 Imunologia e Infecção